Drug Launch Tracker

Brand-Name Drugs Starting With G

The month or window each one is expected to get its first, lower-cost generic. Each drug opens its own launch page with the patents, approvals and prices behind its month.

Dr. Brian Staiger, PharmD, BCPS

This list is aggregated from FDA records, court filings and company announcements. Coded and designed by

Updated October 9, 2026 How we build our data

G

  • Galafold Migalastat Hydrochloride January 2037
  • Ganciclovir Ganciclovir September 2034
  • Gavreto Pralsetinib April 2039
  • Gelnique Oxybutynin Chloride No date yet
  • Gemtesa Vibegron 2038 to 2039
  • GeNOsyl Nitric Oxide July 2040
  • Genvoya Cobicistat, Elvitegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate Sometime in 2032
  • Giapreza Angiotensin II Acetate 2031 to 2032
  • Giazo Balsalazide Disodium No date yet
  • Gilenya Fingolimod Hydrochloride No date yet
  • Gilotrif Afatinib Dimaleate 2027 to 2028
  • Gimoti Metoclopramide 2032 to 2033
  • Givlaari Givosiran Sodium October 2034
  • Gloperba Colchicine 2027 to 2028
  • Glyxambi Empagliflozin and Linagliptin 2032 to 2033
  • Gocovri Amantadine Hydrochloride March 2030
  • Gomekli Mirdametinib 2039 to 2040
  • Gozellix Gallium Ga-68 Gozetotide July 2035
  • Grafapex Treosulfan January 2032
  • Gvoke Glucagon April 2036
  • Gvoke HypoPen Glucagon April 2036
  • Gvoke PFS Glucagon April 2036
  • Gwyn Lo Ethinyl Estradiol and Norelgestromin July 2029

See every expected first generic month by month on Generic Launches. Not seeing yours? Ask a pharmacist and we will look it up.